Systematic review of immunomodulatory therapies for hidradenitis suppurativa
Shi Yu Derek Lim,1 Hazel H Oon21Internal Medicine Residency, National Healthcare Group, Singapore, Singapore; 2Department of Dermatology, National Skin Centre, Singapore, SingaporeBackground: Greater understanding of the roles of tumor necrosis factor-α, IL-1β, IL-10, and the IL-2...
Guardado en:
Autores principales: | Lim SYD, Oon HH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff7ff9ad9eff4c3380960a44698e56b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
por: E. V. Voronina, et al.
Publicado: (2018) -
Evaluación del tratamiento con infliximab en enfermos con artritis inflamatoria refractaria a drogas habituales
por: Labarca S,Cristián, et al.
Publicado: (2003) -
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
por: Alvisi P, et al.
Publicado: (2019) -
Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Aline Lissa Okita, et al.
Publicado: (2020) -
Infliximab en el tratamiento de la enfermedad de Crohn: Estudio preliminar
por: Gellona V,José, et al.
Publicado: (2006)